Keywords: gw, reports, loss, reduction, l6, 7m, uk-based

GW reports 2.6% loss reduction to L6.7M

Article | 25 June 2007

Print This

UK-based drugmaker GW Pharmaceuticals says that, for the six months ended March 31, 2007, its net loss was L6.7 million ($13.3 million), an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in